Evidence map›Paper›PMID 38203383›Full record

ArticleInternational journal of molecular sciences2023

Development of a Gene-Based Marker Set for Orange-Colored Watermelon Flesh with a High β-Carotene Content.

Bingkui Jin, Gaeun Jang, Girim Park, Durre Shahwar, Jagyeong Shin, Gibeom Kwon, Yongjae Kim, Hoytaek Kim, Oakjin Lee, Younghoon Park

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Bingkui JinDepartment of Horticultural Bioscience, Pusan National University, Miryang 50463, Republic of Korea.
Gaeun JangDepartment of Horticultural Bioscience, Pusan National University, Miryang 50463, Republic of Korea.
Girim ParkDepartment of Horticultural Bioscience, Pusan National University, Miryang 50463, Republic of Korea.
Durre ShahwarDepartment of Horticultural Bioscience, Pusan National University, Miryang 50463, Republic of Korea.
Jagyeong ShinDepartment of Horticultural Bioscience, Pusan National University, Miryang 50463, Republic of Korea.
Gibeom KwonPartner Seeds Co., Ltd., Gimje 54324, Republic of Korea.
Yongjae KimPartner Seeds Co., Ltd., Gimje 54324, Republic of Korea.
Hoytaek KimDepartment of Horticulture, Sunchon National University, Sunchon 57922, Republic of Korea.
Oakjin LeeNational Institute of Horticultural and Herbal Science, Rural Development Administration, Wanju 55365, Republic of Korea.
Younghoon ParkDepartment of Horticultural Bioscience, Pusan National University, Miryang 50463, Republic of Korea.ORCID 0000-0003-4016-8652
Pusan National University · KRRural Development Administration · KRSunchon National University · KR

Funding

Rural Development Administration PJ014846012020
6 · The paper itself

Abstract

The fruit flesh of watermelons differs depending on the distinct carotenoid composition. Orange-colored flesh relates to the accumulation of β-carotene, which is beneficial to human health. Canary-yellow-fleshed OTO-DAH and orange-β-fleshed (orange-fleshed with high β-carotene) NB-DAH near-isogenic lines (NILs) were used to determine the genetic mechanism attributed to orange watermelon flesh. For genetic mapping, an F

Indexed as

beta CarotenePlant BreedingCarotenoidsChromosome MappingGenetic MarkersHumansbeta CaroteneCarotenoidsGenetic Markersnear-isogenic lineorange fleshwatermelon fleshβ-carotene

Identifiers

PMID38203383
PMCPMC10778947
OpenAlexW4390175413

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.